<p>Deltec Asset Management LLC 在第三季度購買了 Intuitive Surgical, Inc. (NASDAQ:ISRG - 免費報告) 的新股份，根據其最近向證券交易委員會提交的 13F 表格。該基金購買了 2,000 股該醫療設備提供商的股票，價值約 894,000 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
<ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
<p>其他一些對沖基金和機構投資者最近也對該股票的持倉進行了調整。Trilogy Capital Inc. 在第三季度將其在 Intuitive Surgical 的持股增加了 23.8%。Trilogy Capital Inc. 現在擁有 5,406 股該醫療設備提供商的股票，價值 2,418,000 美元，此前在上個季度又購買了 1,038 股。Forum Financial Management LP 在第三季度將其在 Intuitive Surgical 的持倉增加了 23.3%。Forum Financial Management LP 現在擁有 2,624 股該醫療設備提供商的股票，價值 1,174,000 美元，此前在此期間又購買了 495 股。Legacy Trust 在第三季度將其在 Intuitive Surgical 的持倉增加了 3.5%。Legacy Trust 現在擁有 11,291 股該醫療設備提供商的股票，價值 5,050,000 美元，此前在此期間又購買了 379 股。Fairfield Financial Advisors LTD 在第三季度將其在 Intuitive Surgical 的持倉增加了 1.7%。Fairfield Financial Advisors LTD 現在擁有 6,688 股該醫療設備提供商的股票，價值 2,991,000 美元，此前在此期間又購買了 113 股。最後，Parnassus Investments LLC 在第三季度將其在 Intuitive Surgical 的持倉增加了 2.8%。Parnassus Investments LLC 現在擁有 2,789 股該醫療設備提供商的股票，價值 1,247,000 美元，此前在上個季度又購買了 77 股。對沖基金和其他機構投資者持有該公司 83.64% 的股票。</p>
<h2>內部人士下注</h2>
<p>在其他新聞中，SVP Mark Brosius 於 12 月 12 日星期五出售了 4,500 股該公司的股票。該股票以平均價格 547.36 美元出售，總交易額為 2,463,120.00 美元。出售完成後，該高級副總裁在公司中持有 907 股，價值約 496,455.52 美元。該交易使其持倉減少了 83.23%。該出售在向證券交易委員會提交的文件中披露，您可以通過此鏈接訪問。此外，內部人士 Gary S. Guthart 於 10 月 24 日星期五出售了 28,800 股該股票。該股票以平均價格 547.56 美元出售，總交易額為 15,769,728.00 美元。出售後，內部人士直接持有 27,027 股該公司的股票，價值約 14,798,904.12 美元。此交易使其持倉減少了 51.59%。有關此出售的更多詳細信息可在官方 SEC 披露中找到。在過去的九十天裏，內部人士出售了價值 63,533,844 美元的 114,007 股公司股票。0.70% 的股票由內部人士持有。</p>
<h2>分析師評級上調和下調</h2>
<ul>
<li>在特朗普關税政策下表現突出的前三隻股票</li>
</ul>
<p>幾家研究公司最近對 ISRG 進行了評估。滙豐銀行將 Intuitive Surgical 的目標價格從 595.00 美元上調至 644.00 美元，並在 10 月 23 日的研究報告中給予該公司 &#34;買入&#34; 評級。瑞銀集團對 Intuitive Surgical 設定了 600.00 美元的目標價格，並在 10 月 23 日的研究報告中給予該公司 &#34;中性&#34; 評級。Sanford C. Bernstein 重申了 &#34;跑贏大盤&#34; 的評級，並在週五的研究報告中對 Intuitive Surgical 的股票發佈了 740.00 美元的目標價格（上調自 700.00 美元）。Rothschild &amp; Co Redburn 將 Intuitive Surgical 的股票目標價格從 610.00 美元上調至 615.00 美元，並在 10 月 23 日的研究報告中給予該公司 &#34;買入&#34; 評級。最後，傑富瑞金融集團將 Intuitive Surgical 的股票目標價格從 550.00 美元上調至 560.00 美元，並在 10 月 22 日的研究報告中給予該股票 &#34;持有&#34; 評級。兩位股票研究分析師對該股票給予了強烈買入評級，十六位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;適度買入&#34;，平均目標價格為 622.17 美元。</p>
<p><strong>查看我們最新的 ISRG 股票分析</strong></p>
<h2>Intuitive Surgical 股票上漲 0.2%</h2>
<ul>
<li>為什麼 Intuitive Surgical 對長期投資者來説是個明智的選擇</li>
</ul>
<p>ISRG 的股票在星期五開盤價為 586.24 美元。Intuitive Surgical, Inc. 的 52 周低點為 425.00 美元，52 周高點為 616.00 美元。該公司的 50 日移動平均線為 565.95 美元，200 日移動平均線為 511.45 美元。該公司的市值為 2,101.6 億美元，市盈率為 77.55，市盈率增長比率為 4.77，貝塔係數為 1.67。</p>
<p>Intuitive Surgical (NASDAQ:ISRG - 獲取免費報告) 最近於 10 月 21 日星期二發佈了其財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。Intuitive Surgical 的股本回報率為 15.08%，淨利潤率為 28.58%。該公司的季度收入為 25.1 億美元，而分析師預期為 24.1 億美元。在去年同期，該公司每股收益為 1.84 美元。該公司的季度收入同比增長 22.9%。整體來看，股票研究分析師預計 Intuitive Surgical, Inc. 在本年度將發佈 6.43 美元的每股收益。</p>
<h2>關於 Intuitive Surgical</h2>
<p>(免費報告)</p>
<p>直覺外科成立於 1995 年，總部位於加利福尼亞州的陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療科技公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺外科的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室內的精確度、可視化和控制能力。</p>
<p>除了核心手術平台外，直覺外科還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>另見</h2>
<ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>埃隆將 SpaceX 上市！$100 的首次公開募股機會！</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
<li>股票代碼揭曉：首次公開募股接入 “下一個埃隆·馬斯克” 公司</li>
<li>自 2007 年以來首次：所有警告均已激活</li>
<li>富人如何退休</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資$1,000 在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

直覺外科

<p>Deltec Asset Management LLC 已經在 Intuitive Surgical, Inc. (NASDAQ:ISRG) 中獲得了新的股份，購買了價值約 894,000 美元的 2,000 股。其他機構投資者，包括 Trilogy Capital Inc. 和 Forum Financial Management LP，也增加了對該公司的持股。最近的內部銷售包括高級副總裁 Mark Brosius 和內部人士 Gary S. Guthart 的重大交易。分析師們已提高了對 ISRG 的目標價格，滙豐銀行設定了新的目標價為 644.00 美元，市場共識評級為 “適度買入”，平均目標價格為 622.17 美元</p>

<p>Deltec Asset Management LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities &amp; Exchange Commission. The fund purchased 2,000 shares of the medical equipment provider's stock, valued at approximately $894,000.</p>
<div class="lb-trans"><p>Deltec Asset Management LLC 在第三季度購買了 Intuitive Surgical, Inc. (NASDAQ:ISRG - 免費報告) 的新股份，根據其最近向證券交易委員會提交的 13F 表格。該基金購買了 2,000 股該醫療設備提供商的股票，價值約 894,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Trilogy Capital Inc. increased its holdings in shares of Intuitive Surgical by 23.8% in the 3rd quarter. Trilogy Capital Inc. now owns 5,406 shares of the medical equipment provider's stock valued at $2,418,000 after purchasing an additional 1,038 shares in the last quarter. Forum Financial Management LP grew its position in Intuitive Surgical by 23.3% during the third quarter. Forum Financial Management LP now owns 2,624 shares of the medical equipment provider's stock worth $1,174,000 after buying an additional 495 shares during the period. Legacy Trust grew its position in Intuitive Surgical by 3.5% during the third quarter. Legacy Trust now owns 11,291 shares of the medical equipment provider's stock worth $5,050,000 after buying an additional 379 shares during the period. Fairfield Financial Advisors LTD lifted its position in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Fairfield Financial Advisors LTD now owns 6,688 shares of the medical equipment provider's stock valued at $2,991,000 after acquiring an additional 113 shares during the period. Finally, Parnassus Investments LLC boosted its stake in shares of Intuitive Surgical by 2.8% during the 3rd quarter. Parnassus Investments LLC now owns 2,789 shares of the medical equipment provider's stock worth $1,247,000 after acquiring an additional 77 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>其他一些對沖基金和機構投資者最近也對該股票的持倉進行了調整。Trilogy Capital Inc. 在第三季度將其在 Intuitive Surgical 的持股增加了 23.8%。Trilogy Capital Inc. 現在擁有 5,406 股該醫療設備提供商的股票，價值 2,418,000 美元，此前在上個季度又購買了 1,038 股。Forum Financial Management LP 在第三季度將其在 Intuitive Surgical 的持倉增加了 23.3%。Forum Financial Management LP 現在擁有 2,624 股該醫療設備提供商的股票，價值 1,174,000 美元，此前在此期間又購買了 495 股。Legacy Trust 在第三季度將其在 Intuitive Surgical 的持倉增加了 3.5%。Legacy Trust 現在擁有 11,291 股該醫療設備提供商的股票，價值 5,050,000 美元，此前在此期間又購買了 379 股。Fairfield Financial Advisors LTD 在第三季度將其在 Intuitive Surgical 的持倉增加了 1.7%。Fairfield Financial Advisors LTD 現在擁有 6,688 股該醫療設備提供商的股票，價值 2,991,000 美元，此前在此期間又購買了 113 股。最後，Parnassus Investments LLC 在第三季度將其在 Intuitive Surgical 的持倉增加了 2.8%。Parnassus Investments LLC 現在擁有 2,789 股該醫療設備提供商的股票，價值 1,247,000 美元，此前在上個季度又購買了 77 股。對沖基金和其他機構投資者持有該公司 83.64% 的股票。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other news, SVP Mark Brosius sold 4,500 shares of the business's stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. The trade was a 83.23% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the sale, the insider directly owned 27,027 shares of the company's stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他新聞中，SVP Mark Brosius 於 12 月 12 日星期五出售了 4,500 股該公司的股票。該股票以平均價格 547.36 美元出售，總交易額為 2,463,120.00 美元。出售完成後，該高級副總裁在公司中持有 907 股，價值約 496,455.52 美元。該交易使其持倉減少了 83.23%。該出售在向證券交易委員會提交的文件中披露，您可以通過此鏈接訪問。此外，內部人士 Gary S. Guthart 於 10 月 24 日星期五出售了 28,800 股該股票。該股票以平均價格 547.56 美元出售，總交易額為 15,769,728.00 美元。出售後，內部人士直接持有 27,027 股該公司的股票，價值約 14,798,904.12 美元。此交易使其持倉減少了 51.59%。有關此出售的更多詳細信息可在官方 SEC 披露中找到。在過去的九十天裏，內部人士出售了價值 63,533,844 美元的 114,007 股公司股票。0.70% 的股票由內部人士持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調和下調</h2>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普關税政策下表現突出的前三隻股票</li>
</ul>
</div><p>Several research firms recently weighed in on ISRG. HSBC raised their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, October 23rd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a &#34;neutral&#34; rating in a research report on Thursday, October 23rd. Sanford C. Bernstein reiterated an &#34;outperform&#34; rating and issued a $740.00 price objective (up from $700.00) on shares of Intuitive Surgical in a research report on Friday. Rothschild &amp; Co Redburn increased their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, October 23rd. Finally, Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a &#34;hold&#34; rating in a research report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $622.17.</p>
<div class="lb-trans"><p>幾家研究公司最近對 ISRG 進行了評估。滙豐銀行將 Intuitive Surgical 的目標價格從 595.00 美元上調至 644.00 美元，並在 10 月 23 日的研究報告中給予該公司 &#34;買入&#34; 評級。瑞銀集團對 Intuitive Surgical 設定了 600.00 美元的目標價格，並在 10 月 23 日的研究報告中給予該公司 &#34;中性&#34; 評級。Sanford C. Bernstein 重申了 &#34;跑贏大盤&#34; 的評級，並在週五的研究報告中對 Intuitive Surgical 的股票發佈了 740.00 美元的目標價格（上調自 700.00 美元）。Rothschild &amp; Co Redburn 將 Intuitive Surgical 的股票目標價格從 610.00 美元上調至 615.00 美元，並在 10 月 23 日的研究報告中給予該公司 &#34;買入&#34; 評級。最後，傑富瑞金融集團將 Intuitive Surgical 的股票目標價格從 550.00 美元上調至 560.00 美元，並在 10 月 22 日的研究報告中給予該股票 &#34;持有&#34; 評級。兩位股票研究分析師對該股票給予了強烈買入評級，十六位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;適度買入&#34;，平均目標價格為 622.17 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on ISRG</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 ISRG 股票分析</strong></p>
</div><h2>Intuitive Surgical Stock Up 0.2%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票上漲 0.2%</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼 Intuitive Surgical 對長期投資者來説是個明智的選擇</li>
</ul>
</div><p>Shares of ISRG opened at $586.24 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The company's fifty day moving average is $565.95 and its two-hundred day moving average is $511.45. The firm has a market cap of $210.16 billion, a PE ratio of 77.55, a price-to-earnings-growth ratio of 4.77 and a beta of 1.67.</p>
<div class="lb-trans"><p>ISRG 的股票在星期五開盤價為 586.24 美元。Intuitive Surgical, Inc. 的 52 周低點為 425.00 美元，52 周高點為 616.00 美元。該公司的 50 日移動平均線為 565.95 美元，200 日移動平均線為 511.45 美元。該公司的市值為 2,101.6 億美元，市盈率為 77.55，市盈率增長比率為 4.77，貝塔係數為 1.67。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the company posted $1.84 EPS. The business's quarterly revenue was up 22.9% on a year-over-year basis. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.</p>
<div class="lb-trans"><p>Intuitive Surgical (NASDAQ:ISRG - 獲取免費報告) 最近於 10 月 21 日星期二發佈了其財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。Intuitive Surgical 的股本回報率為 15.08%，淨利潤率為 28.58%。該公司的季度收入為 25.1 億美元，而分析師預期為 24.1 億美元。在去年同期，該公司每股收益為 1.84 美元。該公司的季度收入同比增長 22.9%。整體來看，股票研究分析師預計 Intuitive Surgical, Inc. 在本年度將發佈 6.43 美元的每股收益。</p>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>關於 Intuitive Surgical</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直覺外科成立於 1995 年，總部位於加利福尼亞州的陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療科技公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺外科的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室內的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手術平台外，直覺外科還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>Ticker Revealed: Pre-IPO Access to &#34;Next Elon Musk&#34; Company</li>
<li>First Time Since 2007: All Warnings Active</li>
<li>How the Rich Retire</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>埃隆將 SpaceX 上市！$100 的首次公開募股機會！</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
<li>股票代碼揭曉：首次公開募股接入 “下一個埃隆·馬斯克” 公司</li>
<li>自 2007 年以來首次：所有警告均已激活</li>
<li>富人如何退休</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Deltec Asset Management LLC 購買了 Intuitive Surgical, Inc.（直覺外科公司）的新股份 $ISRG